565 related articles for article (PubMed ID: 10099066)
1. Comparative efficacy and safety of once-daily versus twice-daily loratadine-pseudoephedrine combinations versus placebo in seasonal allergic rhinitis.
Kaiser HB; Banov CH; Berkowitz RR; Bernstein DI; Bronsky EA; Georgitis JW; Mendelson LM; Rooklin AR; Sholler LJ; Stricker WW; Harrison JE; Danzig MR; Lorber RR
Am J Ther; 1998 Jul; 5(4):245-51. PubMed ID: 10099066
[TBL] [Abstract][Full Text] [Related]
2. Comparative efficacy and safety of a once-daily loratadine-pseudoephedrine combination versus its components alone and placebo in the management of seasonal allergic rhinitis.
Bronsky E; Boggs P; Findlay S; Gawchik S; Georgitis J; Mansmann H; Sholler L; Wolfe J; Meltzer E; Morris R
J Allergy Clin Immunol; 1995 Aug; 96(2):139-47. PubMed ID: 7636050
[TBL] [Abstract][Full Text] [Related]
3. SCH 434: a new antihistamine/decongestant for seasonal allergic rhinitis.
Storms WW; Bodman SF; Nathan RA; Chervinsky P; Banov CH; Dockhorn RJ; Jarmoszuk I; Zeitz HJ; McGeady SJ; Pinnas JL
J Allergy Clin Immunol; 1989 Jun; 83(6):1083-90. PubMed ID: 2471718
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of desloratadine/pseudoephedrine tablet, 2.5/120 mg two times a day, versus individual components in the treatment of patients with seasonal allergic rhinitis.
Chervinsky P; Nayak A; Rooklin A; Danzig M
Allergy Asthma Proc; 2005; 26(5):391-6. PubMed ID: 16450574
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the combinations of fexofenadine-pseudoephedrine and loratadine-montelukast in the treatment of seasonal allergic rhinitis.
Moinuddin R; deTineo M; Maleckar B; Naclerio RM; Baroody FM
Ann Allergy Asthma Immunol; 2004 Jan; 92(1):73-9. PubMed ID: 14756468
[TBL] [Abstract][Full Text] [Related]
6. Loratadine/pseudoephedrine for nasal symptoms in seasonal allergic rhinitis: a double-blind, placebo-controlled study.
McFadden EA; Gungor A; Ng B; Mamikoglu B; Moinuddin R; Corey J
Ear Nose Throat J; 2000 Apr; 79(4):254, 257-8, 260 passim. PubMed ID: 10786387
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of an extended-release formulation of desloratadine and pseudoephedrine vs the individual components in the treatment of seasonal allergic rhinitis.
Pleskow W; Grubbe R; Weiss S; Lutsky B
Ann Allergy Asthma Immunol; 2005 Mar; 94(3):348-54. PubMed ID: 15801245
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of loratadine and pseudoephedrine following single and multiple doses of once- versus twice-daily combination tablet formulations in healthy adult males.
Kosoglou T; Radwanski E; Batra VK; Lim JM; Christopher D; Affrime MB
Clin Ther; 1997; 19(5):1002-12. PubMed ID: 9385487
[TBL] [Abstract][Full Text] [Related]
9. A comparative study of the side effects between pseudoephedrine in Loratadine plus Pseudoephedrine Sulfate Repetabs Tables and loratadine + pseudoephedrine tablet in treatment of allergic rhinitis in Thai patients.
Supiyaphun P; Chochaipanichnon L; Kerekhanjanarong V; Saengpanich S
J Med Assoc Thai; 2002 Jun; 85(6):722-7. PubMed ID: 12322847
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of fixed-dose loratadine/montelukast in seasonal allergic rhinitis: effects on nasal congestion.
Prenner B; Anolik R; Danzig M; Yao R
Allergy Asthma Proc; 2009; 30(3):263-9. PubMed ID: 19549427
[TBL] [Abstract][Full Text] [Related]
11. Double-blind trials of azelastine nasal spray monotherapy versus combination therapy with loratadine tablets and beclomethasone nasal spray in patients with seasonal allergic rhinitis. Rhinitis Study Groups.
Berger WE; Fineman SM; Lieberman P; Miles RM
Ann Allergy Asthma Immunol; 1999 Jun; 82(6):535-41. PubMed ID: 10400480
[TBL] [Abstract][Full Text] [Related]
12. The risk of esophageal obstruction associated with an anti-allergy medication (Claritin-D 24-Hour--original formulation).
Manda B; Drinkard CR; Shatin D; Graham DJ
Pharmacoepidemiol Drug Saf; 2004 Jan; 13(1):29-34. PubMed ID: 14971120
[TBL] [Abstract][Full Text] [Related]
13. Comparative study of SCH 434 and CTM-D in the treatment of seasonal allergic rhinitis.
Prevost M; Turenne Y; Moote DW; Mazza J; Clermont A; PetitClerc C; Danzig MR
Clin Ther; 1994; 16(1):50-6. PubMed ID: 7911402
[TBL] [Abstract][Full Text] [Related]
14. A randomized, double-blind, parallel-group study to compare the efficacy and safety of a once-daily loratadine-pseudoephedrine combination with that of a twice-daily loratadine-pseudoephedrine combination in the treatment of allergic rhinitis.
Chen YA; Chang KP; Lin YS; Hao SP
Eur Arch Otorhinolaryngol; 2007 Sep; 264(9):1019-25. PubMed ID: 17464511
[TBL] [Abstract][Full Text] [Related]
15. Comparison of intranasal triamcinolone acetonide with oral loratadine for the treatment of patients with seasonal allergic rhinitis.
Schoenwetter W; Lim J
Clin Ther; 1995; 17(3):479-92. PubMed ID: 7585852
[TBL] [Abstract][Full Text] [Related]
16. [Evaluation of the efficiency and safety of the loratadine with pseudoephedrine combination drug in treatment of seasonal allergic rhinitis].
Zawisza E; Lipiec A; Rapiejko P
Pol Merkur Lekarski; 1998 Feb; 4(20):66-8. PubMed ID: 9634291
[TBL] [Abstract][Full Text] [Related]
17. Loratadine-pseudoephedrine combination versus placebo in patients with seasonal allergic rhinitis.
Grossman J; Bronsky EA; Lanier BQ; Linzmayer MI; Moss BA; Schenkel EJ; Selner JC
Ann Allergy; 1989 Oct; 63(4):317-21. PubMed ID: 2529798
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of once-daily desloratadine/pseudoephedrine for relief of nasal congestion.
Schenkel E; Corren J; Murray JJ
Allergy Asthma Proc; 2002; 23(5):325-30. PubMed ID: 12476542
[TBL] [Abstract][Full Text] [Related]
19. [Assessment of the clinical efficacy and safety of epinastine plus pseudoephedrine vs loratadine plus pseudoephedrine in perennial allergic rhinitis].
Hernández Colín D; González Díaz SN; Rodríguez Medina R; Aguilar Angeles D; González Gámez J; Becerril Angeles M; Orea Solano M; Domínguez Henkel R; Segovia Ayala C
Rev Alerg Mex; 2004; 51(1):23-8. PubMed ID: 15119752
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of azelastine nasal spray in patients with an unsatisfactory response to loratadine.
Berger WE; White MV;
Ann Allergy Asthma Immunol; 2003 Aug; 91(2):205-11. PubMed ID: 12952117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
